Literature DB >> 7970444

Usefulness of 99Tcm-N,N'-ethylene-1-dicysteine complex for dynamic kidney investigations.

M J Surma1, J Wiewióra, J Liniecki.   

Abstract

To assess the usefulness of the 99Tcm-N,N'-ethylene-1-dicysteine (99Tcm-EC) complex for examination of kidney function, dynamic kidney scintigraphy with 99Tcm-EC and clearance determinations were performed. During renoscintigraphy the kidney images were of superb quality, with overlying organs (liver, spleen) not visualized. Renograms showed typical shapes, their Tmax and T1/2 values being unsignificantly different from the values obtained with other radiopharmaceuticals used in renoscintigraphy (mercaptoacetyl triglycine, hippuran). Very strict correlations were found between values of 99Tcm-EC and 131I-iodohippurate (OIH) clearances (r = 0.91) and excretion rate constants (r = 0.92) for both radiopharmaceuticals. The correlation enabled the formulation of an equation by which effective renal plasma flow (ERPF) could be established from 99Tcm-EC clearance: ERPFOIH = 1.245 x ClEC + 51.52. On the basis of this equation a lower boundary of the normal 99Tcm-EC clearance was established; it amounts to 300 ml min-1 1.73 m-2.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7970444     DOI: 10.1097/00006231-199408000-00007

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  4 in total

1.  Simplified determination of technetium-99m ethylenedicysteine clearance from a single plasma sample: what is the upper normal range?

Authors:  L Kabasakal; C Onsel
Journal:  Eur J Nucl Med       Date:  1996-11

2.  Noninvasive assessment of tumor hypoxia with 99mTc labeled metronidazole.

Authors:  D J Yang; S Ilgan; T Higuchi; F Zareneyrizi; C S Oh; C W Liu; E E Kim; D A Podoloff
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

3.  Molecular imaging of Bcr-Abl phosphokinase in a xenograft model.

Authors:  Ji Yuan Wu; David J Yang; Laura S Angelo; Saady Kohanim; Razelle Kurzrock
Journal:  Mol Cancer Ther       Date:  2009-03-03       Impact factor: 6.261

4.  Technetium-99m-L,L-ethylenedicysteine scintigraphy in patients with renal disorders.

Authors:  N K Gupta; J B Bomanji; W Waddington; D Lui; D C Costa; A M Verbruggen; P J Ell
Journal:  Eur J Nucl Med       Date:  1995-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.